Want to see ACIU full AI Analyst Report?
AC Immune SA (ACIU) Stock Statistics & Valuation Metrics
Total Valuation
AC Immune SA has a market cap or net worth of $225.94M. The enterprise value is $128.48M.
- Market Cap
- $225.94M
- Enterprise Value
- $128.48M
Share Statistics
AC Immune SA has 101,773,575 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 101,773,575
- Owned by Insiders
- 4.12%
- Owned by Institutions
- 1.03%
Financial Efficiency
AC Immune SA’s return on equity (ROE) is -1.57 and return on invested capital (ROIC) is -113.87%.
- Return on Equity (ROE)
- -1.57
- Return on Assets (ROA)
- -0.46
- Return on Invested Capital (ROIC)
- -113.87%
- Return on Capital Employed (ROCE)
- -1.15
- Revenue Per Employee
- 33.71K
- Profits Per Employee
- -664.59K
- Employee Count
- 106
- Asset Turnover
- 0.02
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of AC Immune SA is -4.25. AC Immune SA’s PEG ratio is 0.21.
- PE Ratio
- -4.25
- PS Ratio
- 10.64
- PB Ratio
- 5.14
- Price to FCF
- -5.33
- Price to Operating Cash Flow
- -5.19
- PEG Ratio
- 0.21
Income Statement
In the last 12 months, AC Immune SA had revenue of 3.57M and earned -70.45M in profits. Earnings per share was -0.70.
- Revenue
- 3.57M
- Gross Profit
- 3.57M
- Operating Income
- -68.86M
- Pretax Income
- -70.45M
- Net Income
- -70.45M
- EBITDA
- -67.75M
- Earnings Per Share (EPS)
- -0.70
Cash Flow
In the last 12 months, operating cash flow was -34.79M and capital expenditures -165,163, giving a free cash flow of -34.95M billion.
- Operating Cash Flow
- -34.79M
- Free Cash Flow
- -34.95M
- Free Cash Flow per Share
- -0.35
Dividends & Yields
AC Immune SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -18.75%
- Earnings Yield
- -23.88%
Stock Price Statistics
- Beta
- 1.27
- 52-Week Price Change
- -34.32%
- 50-Day Moving Average
- 2.61
- 200-Day Moving Average
- 2.71
- Relative Strength Index (RSI)
- 36.17
- Average Volume (3m)
- 199.08K
Important Dates
AC Immune SA upcoming earnings date is Nov 10, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- Nov 10, 2026
- Ex-Dividend Date
- ―
Financial Position
AC Immune SA as a current ratio of 1.02, with Debt / Equity ratio of 10.12%
- Current Ratio
- 1.02
- Quick Ratio
- 1.02
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.33
- Interest Coverage Ratio
- -360.54
Taxes
In the past 12 months, AC Immune SA has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
AC Immune SA EV to EBITDA ratio is -3.90, with an EV/FCF ratio of -4.66.
- EV to Sales
- 9.29
- EV to EBITDA
- -3.90
- EV to Free Cash Flow
- -4.66
- EV to Operating Cash Flow
- -4.68
Balance Sheet
AC Immune SA has $75.36M in cash and marketable securities with $4.10M in debt, giving a net cash position of $71.25M billion.
- Cash & Marketable Securities
- $75.36M
- Total Debt
- $4.10M
- Net Cash
- $71.25M
- Net Cash Per Share
- $0.70
- Tangible Book Value Per Share
- -$0.15
Margins
Gross margin is 100.00%, with operating margin of -252.25%, and net profit margin of -246.49%.
- Gross Margin
- 100.00%
- Operating Margin
- -252.25%
- Pretax Margin
- -246.49%
- Net Profit Margin
- -246.49%
- EBITDA Margin
- -238.29%
- EBIT Margin
- -245.53%
Analyst Forecast
The average price target for AC Immune SA is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $10.00
- Price Target Upside
- 350.45% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- -33.68%
- EPS Growth Forecast
- 4.48%
Scores
- Smart Score
- 6
- AI Score
- 46
